Skip to main content
BMC is moving to Springer Nature Link. Visit this journal in its new home.

Featured Article: Detection of early relapse in multiple myeloma patients

Multiple myeloma remains a hard to treat disease, as almost all patients relapse. It is currently not possible to predict when relapse will occur, but studies suggest that microRNAs could be good markers of relapse. 

Public domain image from https://commons.wikimedia.org/wiki/File:Multiple_myeloma_(1)_MG_stain.jpg

Articles

Call for Papers: New Biomarkers of Solid and Hematological Malignancies

Cell Division is calling for submissions to our Collection on New Biomarkers of Solid and Hematological Malignancies. This Collection focuses on the latest discoveries of biomarkers in both solid and hematological malignancies, aiming to highlight their potential in improving cancer diagnosis, prognosis, and personalized therapy.

Read More

Aims and scope

Cell Division is an open access, peer-reviewed journal, which publishes articles in areas including, but not limited to, molecular aspects of cell cycle control and cancer, cell growth, proliferation, survival, differentiation, signalling, gene transcription, protein synthesis, genome integrity, chromosome stability, centrosome duplication, DNA damage and DNA repair.

Read more

Annual Journal Metrics

  • Citation Impact 
    Journal Impact Factor: 2.2 (2024)    
    5-year Journal Impact Factor: 2.3 (2024)    
    Source Normalized Impact per Paper (SNIP): 0.548 (2024)    
    SCImago Journal Rank (SJR): 0.768 (2024)

    Speed 
    Submission to first editorial decision (median days): 12
    Submission to acceptance (median days): 128

    Usage 2024
    Downloads: 179,933
    Altmetric mentions: 38